Asia Pacific Colorectal Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

No. of Pages: 151    |    Report Code: BMIRE00028831    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Colorectal Cancer Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Colorectal Cancer Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Colorectal Cancer Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Colorectal Cancer
  • 5.1.2 Launches of New Products
5.2 Market Opportunities
  • 5.2.1 Growing Awareness of Colorectal Cancer
5.3 Future Trends
  • 5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact of Drivers and Restraints

6. Asia Pacific Colorectal Cancer Diagnostics Market Regional Analysis

6.1 Asia Pacific Colorectal Cancer Diagnostics Market Overview
6.2 Asia Pacific Colorectal Cancer Diagnostics Market Revenue 2021-2028 (US$ Million)
6.3 Asia Pacific Colorectal Cancer Diagnostics Market Forecast Analysis

7. Asia Pacific Colorectal Cancer Diagnostics Market Analysis – by Modality

7.1 Imaging Tests
  • 7.1.1 Overview
  • 7.1.2 Imaging Tests: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Stool-Based Tests
  • 7.2.1 Overview
  • 7.2.2 Stool-Based Tests: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Colorectal Cancer Diagnostics Market Analysis – by End User

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diagnostic Laboratories
  • 8.2.1 Overview
  • 8.2.2 Diagnostic Laboratories: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Cancer Research Institutes
  • 8.3.1 Overview
  • 8.3.2 Cancer Research Institutes: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Colorectal Cancer Diagnostics Market – Asia-Pacific Analysis

9.1 Asia-Pacific
  • 9.1.1 Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 9.1.1.1 Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 China: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 China: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Modality
    • 9.1.1.1.2 China: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.2 India: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 India: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Modality
    • 9.1.1.2.2 India: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.3 Japan: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 Japan: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Modality
    • 9.1.1.3.2 Japan: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.4 Australia: Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Australia: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Modality
    • 9.1.1.4.2 Australia: Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.5 Rest of Asia-Pacific : Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by Modality
    • 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Colorectal Cancer Diagnostics Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Asia Pacific Colorectal Cancer Diagnostics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Bruker Corp
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Clinical Genomics Technologies Pty Ltd
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Eiken Chemical Co., Ltd.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Epigenomics AG
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 F. Hoffmann-La Roche Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Illumina Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Medtronic Plc
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Quest Diagnostics Inc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Siemens Healthineers AG
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - A Market

  1. Bruker Corp                                            
  2. Clinical Genomics Technologies Pty Ltd  
  3. Eiken Chemical Co., Ltd.                       
  4. Epigenomics AG                                       
  5. F. Hoffmann-La Roche Ltd                     
  6. Illumina Inc         
  7. Medtronic Plc    
  8. Quest Diagnostics Inc                           
  9. Siemens Healthineers AG                    
asia-pacific-colorectal-cancer-diagnostics-market